Tazverik (tazemetostat)

tazemetostat · Epizyme

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tazverik (tazemetostat), covering 2025-03-06 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Tazemetostat Plus CHOP in 1L T-cell Lymphoma [Phase 2]